The Effects of Preexisting Health Conditions and Vaccination on the COVID-19 Complications

Authors

  • Nasrin Akter Department of Biochemistry & Molecular Biology, Primeasia University, Dhaka, Bangladesh
  • Md. Mejbah Uddin Mithu Department of Public Health & Informatics, Jahangirnagar University, Savar, Dhaka, Bangladesh
  • Md. Ripon Hossain Department of Biochemistry & Molecular Biology, Primeasia University, Dhaka, Bangladesh
  • Rakibul Hasan Department of Biochemistry & Molecular Biology, Primeasia University, Dhaka, Bangladesh
  • Md. Shahinur Karim Department of Biochemistry & Molecular Biology, Primeasia University, Dhaka, Bangladesh
  • Hoymonti Shukla Department of Biochemistry & Molecular Biology, Primeasia University, Dhaka, Bangladesh
  • Mahfuza Mubarak Department of Public Health & Informatics, Jahangirnagar University, Savar, Dhaka, Bangladesh, 4-Green Research Society, Savar, Dhaka, Bangladesh
  • Hasi Rani Saha Department of Biochemistry & Molecular Biology, Primeasia University, Dhaka, Bangladesh
  • Bidhan Chandra Sarker Department of Biochemistry & Molecular Biology, Primeasia University, Dhaka, Bangladesh
  • Dr. Md. Shahinul Islam Assistant Professor, Dept. of Biochemistry, Primeasia University, Dhaka, Department of Biochemistry & Molecular Biology, Primeasia University, Dhaka, Bangladesh, 4-Green Research Society, Savar, Dhaka, Bangladesh

Keywords:

Preexisting health problem, COVID-19 complications, Comorbidities, Vaccination, Long-COVID

Abstract

In recent years, the coronavirus pandemic disease has been more fatal in the world. The presence of several comorbidities, particularly asthma, cardiovascular problems, diabetes, and kidney disease, has been linked to a worse prognosis of COVID-19 infection. This paper examined the progression of the disease, significant health risks, effects of vaccination and COVID-19 complications rates among people with comorbidities. A cross-sectional study has been conducted with direct interviews of 1002 patients in different parts of Bangladesh following a well-organized questionnaire. This study clearly shows that pre-existing health problems are extremely high-risk factors for long-term major health complications such as shortness of breath, hypertension, loss of taste and appetite, mental depression, dementia, uncontrolled blood pressure, and sugar levels during and after recovery from COVID-19 infection.

Among them, almost 70% of asthma and cardiovascular disease patients were suffering from severe health complications, including shortness of breath, hypertension, and mental health problems, after getting the COVID-19 infection. Moreover, it also revealed that vaccination can significantly reduce the severity of COVID complications up to 50% compared to unvaccinated people. The overall finding of this study can be useful for the prediction of possible ways to avoid the life-threatening risk of COVID-19 infection for people who are already suffering from various preexisting health problems.

References

Dasgupta, A., Kalhan, A. and Kalra, S. 2020. Long term complications and rehabilitation of COVID-19 patients. J. Pak. Med. Assoc. 70, 131-135.

COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU), 2020, Available from: https://coronavirus.jhu.edu/map.html Accessed in 2021 (Dec 13).

Halpin, S., O'Connor, R. and Sivan, M. 2021. Long COVID and chronic COVID syndromes, J Med Virol. 93,1242–1243.

Carfì, A., Bernabei, R., Landi, F. 2020. Persistent symptoms in patients after acute COVID-19. JAMA, 324, 603-5.

Halpinn, S.J., McIvor, C., Whyatt, G., Adams, A., Harvey, O. et al. 2020. Post discharge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol. 93(2):1013-22.

Huang, Y., Tan, C., Wu, J., Chen, M., Wang, Z., Luo, L. et al. 2020. Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase. Respir Res. 21(1): 163.

COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU), Available from: https://coronavirus.jhu.edu/map.html Accessed in 2022 (July 13).

https://coronavirus.jhu.edu/ . Last access August, 2022.

Goërtz ,Y. M. J., Van, Herck, M., Delbressine, J.M., Vaes, A.W., Meys, R., Machado, F.V.C. et al. 2020. Persistent symptoms 3 months after a SARS-CoV-2 infection: The post-COVID-19 syndrome? ERJ Open Res. 6: 00542–02020.

Ejaz, H., Alsrhani, A., Zafar, A., Javed, H., Junaid, K., Abdalla, A.E., Abosalif, K.O.A. and Ahmed, Z., Younas, S. 2020. COVID-19 and comorbidities: Deleterious impact on infected patients. Journal of Infection and Public Health, 13(12): 1833-1839.

Docherty, A.B., Harrison, E.M., Green, C.A., Hardwick, H., Pius, R. et al. 2020. Features of 20 133 UK patients in hospital with covid-1 using the ISARIC WHO Clinical Characterisation Protocol: Prospective observational cohort study. BMJ, 369:m1985.

Fang, F.C., Benson, C.A., Rio, C.D., Edwards, K.M., Fowler, V.G., Fredricks, D. et al. 2021. COVID-19—Lessons Learned and Questions Remaining. Clin. Infect. Dis., 72(12): 2225-2240.

Rozen, T.D.2020. Daily persistent headache after a viral illness during a worldwide pandemic may not be a new occurrence: Lessons from the 1890 Russian/Asiatic flu. Cephalalgia, 40(13): 1406-1409.

Ghiasvand, F., Miandoab, S.Z., Harandi, H., Golestan, F.S., Ali naghi, S.A.S. 2020. A patient with COVID-19 disease in a Referral Hospital in Iran: a typical case. Infectious disorders drug targets, 20(4): 559-562.

George, P., Patterson, C., Ak, R. 2019. Lung transplantation for idiopathic pulmonary fibrosis. Lancet Respir Med, 7(3): 271–282.

Tenforde, M.W., Kim , S.S., Lindsell, C.J., Billig, Rose, E., Shapiro, N.I. et al. 2020. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a Multistate Health Care Systems Network — United States, March–June. MMWR. Morb. Mortal. Wkly. Rep. 69: 993–998.

Carfì, A., Bernabei, R., Landi, F. 2020. For the Gemelli against COVID-19 post-acute care study group. Persistent symptoms in patients after acute COVID-19. J Am Med Assoc., 324(6): 603–605.

Rubin, J.E., Crowe, S.E. 2020. Annals of internal medicine®. Ann. Intern. Med., 172: ITC1–ITC14.

Huang, C., Huang, L., Wang, Y., Li, X., Ren, L. et al. 2021. Articles 6-month consequences of COVID-19 in patients discharged from hospital: A Cohort Study., The lancet, 397.

Yashvardhan, B., Cody, K., John, J., Natasha, H., Myriam, B. and Georges, H. 2022. Sequelae and Comorbidities of COVID-19 Manifestations on the Cardiac and the Vascular Systems. Frontiers in Physiology, 12, 748972.

Sanyaolu. A., Okorie, C., Marinkovic, A., Patidar, R., Younis, K., Desai, P., et al. 2020. Comorbidity and its Impact on Patients with COVID-19. SN Compr Clin Med. 2(8):1069-1076.

Buneviciene, I., Bunevicius, R., Bagdonas, S., Bunevicius, A. 2022. The impact of pre-existing conditions and perceived health status on mental health during the COVID-19 pandemic. J Public Health (Oxf). 7;44(1):e88-e95.

Colin, P., Venkatakrishnan, A. J., Eshwan, R., Christian, K. , Arjun, P. , Nikhil, K. 2021. Pre-existing conditions are associated with COVID-19 patients' hospitalization, despite confirmed clearance of SARS-CoV-2 virus. eClinical Medicine, 34, 100793

Hossain, M. A., Hossain, K. M. A., Saunders, K., Uddin, Z. and Walton, L. M., et al. 2021. Prevalence of Long COVID symptoms in Bangladesh: a prospective Inception Cohort Study of COVID-19 survivors. BMJ Global Health, 6: e006838.

Sharif, N., Opu, R.R., Ahmed, S.N., Sarkar, M.K., Jaheen, R. et al. 2021. Prevalence and impact of comorbidities on disease prognosis among patients with COVID-19 in Bangladesh: A nationwide study amid the second wave. Diabetes Metab Syndr.,15(4):102148.

Oran, P.D., and Topol, E.J. 2020. Prevalence of Asymptomatic SARS-CoV-2 Infection. Ann Intern Med., M 20-3012.

AlJishi, J.M., Alhajjaj, A.H., Alkhabbaz, F.L., AlAbduljabar, T.H., Alsaif, A., Alsaif, H., et al. 2021. Clinical characteristics of asymptomatic and symptomatic COVID-19 patients in the Eastern Province of Saudi Arabia. Journal of Infection and Public Health, 14(1): 6-11.

Subramanian A., Nirantharakumar K., Hughes, S. et al. 2022. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med,, 28: 1706–1714.

Nalbandian A. et al. 2021. Post-acute COVID-19 syndrome. Nat. Med., 27, 601–615.

Esmaeilzadeh, H., Sanaei, Dashti A., Mortazavi, N., Fatemian, H., Vali, M. 2022. Persistent cough and asthma-like symptoms post COVID-19 hospitalization in children. BMC Infect Dis.12;22(1):244.

Figliozzi, S., Masci, P.G., Ahmadi, N. et al. 2020. Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis. Eur J Clin Invest, 50:e13362.

Chatterjee, N.A., Cheng, R.K. 2020. Cardiovascular disease and COVID-19: implications for prevention, surveillance and treatment. Heart, 106:1119.

Caballero, A.E., Ceriello, A., Misra, A., Aschner, P., McDonnell, M.E. et al. 2020. Hassanein M, Ji L, Mbanya JC, Fonseca VA. COVID-19 in people living with diabetes: An international consensus. J Diabetes Complications. 34(9):107671.

Guan, W.J., Liang, W.H., Zhao, Y., et al. 2020. Comorbidity and Its Impact on 1590 Patients With COVID-19 in China: A Nationwide Analysis. Eur Respir J, 55(5):2000547.

Ceriello, A., De, Nigris V., Prattichizzo, F. 2020. Why is hyperglycaemia worsening COVID-19 and its prognosis? Diabetes Obes Metab. 22(10):1951-1952.

Long, J.D., Strohbehn, I., Sawtell, R., Bhattacharyya, R., Sise, M.E. 2022. COVID-19 Survival and its impact on chronic kidney disease. Transl Res. 241:70-82.

Oliver, J. W., Gregory, B., Jaspree, T., Alexandra, B. H., Peter, W. and Azra, C. G. 2022. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study, Lancet Infect Dis. 22, (9), P1293-1302.

Downloads

Published

2022-09-25

How to Cite

Nasrin Akter, Md. Mejbah Uddin Mithu, Md. Ripon Hossain, Rakibul Hasan, Md. Shahinur Karim, Hoymonti Shukla, Mahfuza Mubarak, Hasi Rani Saha, Bidhan Chandra Sarker, & Islam, D. M. S. (2022). The Effects of Preexisting Health Conditions and Vaccination on the COVID-19 Complications. International Journal of Sciences: Basic and Applied Research (IJSBAR), 64(1), 66–80. Retrieved from https://www.gssrr.org/index.php/JournalOfBasicAndApplied/article/view/14574

Issue

Vol. 64 No. 1 (2022)

Section

Articles

License

Copyright (c) 2022 International Journal of Sciences: Basic and Applied Research (IJSBAR)

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Authors who submit papers with this journal agree to the following terms.